Published in Arthritis Rheum on December 01, 1958
Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest (1959) 2.56
MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS. J Clin Invest (1963) 1.09
Pharmacology of uricosuric drugs. Ann Rheum Dis (1974) 0.84
NEW DRUGS. Can Med Assoc J (1959) 0.75
Sulphinpyrazone in the treatment of arthritis associated with hyperuricaemia. Proc R Soc Med (1961) 0.75
Comparison of the uricosuric effect of sulfinpyrazone (anturan) and zoxazolamine (flexin). Can Med Assoc J (1960) 0.75
The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 3.60
Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest (1959) 2.56
The fate of pentobarbital in man and dog and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 2.38
Incorporation of glycine nitrogen into uric acid in normal and gouty man. Metabolism (1952) 2.38
Serum alkaline phosphatase activity in diseases of the skeletal and hepatobiliary systems. A consideration of the current status. Am J Med (1959) 2.25
Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Am J Med (1957) 2.24
A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther (1957) 2.20
The renal mechanism for urate excretion in man. J Clin Invest (1950) 2.19
Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs. J Pharmacol Exp Ther (1960) 2.04
Current principles of management in gout. Am J Med (1952) 1.99
EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT. Am J Med (1964) 1.93
Effect of sodium lactate infusion on urate clearance in man. Proc Soc Exp Biol Med (1957) 1.81
Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects. J Clin Invest (1952) 1.77
The metabolic fate of phenylbutazone (butazolidin) in man. J Pharmacol Exp Ther (1955) 1.76
Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects. J Clin Invest (1953) 1.71
A further study of the utilization of dietary glycine nitrogen for uric acid synthesis in gout. J Clin Invest (1953) 1.65
Paradoxical retention of uric acid by uricosuric drugs in low dosage. Proc Soc Exp Biol Med (1955) 1.65
Present status of atherosclerosis as a derangement of lipid metabolism. Am J Med (1953) 1.61
Effects of diet in essential hypertension. II. Results with unmodified Kempner rice diet in 50 hospitalized patients. Am J Med (1950) 1.61
Ascorbic acid synthesis in normal and drug-treated rats, studied with L-ascorbic-1-C14 acid. J Biol Chem (1954) 1.61
Tubular secretion of urate in man. J Clin Invest (1959) 1.60
Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects. Ann Intern Med (1961) 1.59
DRUG INTERACTIONS IN MAN. I. LOWERING EFFECT OF PHENOBARBITAL ON PLASMA LEVELS OF BISHYDROXYCOUMARIN (DICUMAROL) AND DIPHENYLHYDANTOIN (DILANTIN). Clin Pharmacol Ther (1965) 1.55
The synthesis of l-ascorbic acid by the albino rat. J Biol Chem (1950) 1.53
A study, by simultaneous clearance techniques, of salicylate excretion in man: effect of alkalinization of the urine by bicarbonate administration; effect of probenecid. J Clin Invest (1955) 1.50
The purine bases of human urine. I. Separation and identification. J Biol Chem (1957) 1.40
Metabolism of drugs in subjects with Laennec's cirrhosis. Med Exp Int J Exp Med (1959) 1.38
Renal function in Wilson's disease. J Clin Invest (1957) 1.34
The physiological disposition of probenecid, including renal clearance, in man, studied by an improved method for its estimation in biological material. J Pharmacol Exp Ther (1963) 1.33
A simultaneous study of glycine-N15 incorporation into uric acid and heme, and of Fe59 utilization, in a case of gout associated with polycythemia secondary to congenital heart disease. Am J Med (1953) 1.32
Effects of diet in essential hypertension. I. Baseline study: effects in 86 cases of prolonged hospitalization on regular hospital diet. Am J Med (1950) 1.30
Stimulatory effect of foreign compounds on ascorbic acid biosynthesis and on drug-metabolizing enzymes. Nature (1959) 1.26
On the biosynthesis of uric acid from glycine-N15 in primary and secondary polycythemia. Am J Med (1956) 1.23
Missing step in guinea pigs required for the biosynthesis of L-ascorbic acid. Science (1956) 1.22
A three-component system for regulation of renal excretion of uric acid in man. Trans Assoc Am Physicians (1961) 1.22
Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone. Am J Med (1954) 1.22
Incorporation of glycine-1-C14, glycine-2-C14 and glycine-N15 into uric acid in normal and gouty subjects. Am J Med (1958) 1.21
Stimulatory effect of barbital on urinary excretion of L-ascorbic acid and nonconjugated D-glucuronic acid. J Biol Chem (1957) 1.20
Some recent advances in the study of uric acid metabolism and gout. Bull N Y Acad Med (1951) 1.20
Primary and secondary gout. Ann Intern Med (1953) 1.19
Metabolism of ascorbic acid and related uronic acids, aldonic acids, and pentoses. Ann N Y Acad Sci (1961) 1.15
Origin of urinary creatine in progressive muscular dystrophy. Metabolism (1952) 1.14
SIGNIFICANCE OF THE RENAL CLEARANCE OF URIC ACID IN NORMAL AND GOUTY MAN. Am J Med (1964) 1.13
AN ABNORMALITY OF GLUTAMINE METABOLISM IN PRIMARY GOUT. Am J Med (1963) 1.12
Metabolic interactions between L-ascorbic acid and drugs. Ann N Y Acad Sci (1961) 1.12
Renal regulation of uric acid excretion in normal and gouty man; modification by uricosuric agents. Bull N Y Acad Med (1958) 1.12
Gout, a derangement of purine metabolism. Adv Intern Med (1952) 1.10
Effect of pyrazinamide and pyrazinoic acid on urate clearance and other discrete renal functions. Proc Soc Exp Biol Med (1957) 1.10
The metabolism of 1-C14-L-ascorbic acid in guinea pigs. J Biol Chem (1951) 1.10
Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis. Trans Assoc Am Physicians (1951) 1.09
MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS. J Clin Invest (1963) 1.09
A study of the inverse relationship between pKa and rate of renal excretion of phenylbutazone analogs in man and dog. Am J Med (1960) 1.08
Biochemical pharmacological considerations of phenylbutazone and its analogues. Ann N Y Acad Sci (1960) 1.08
The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog. J Pharmacol Exp Ther (1953) 1.08
Prevention and treatment of chronic gouty arthritis. J Am Med Assoc (1955) 1.07
Phenylbutazone metabolites: antirheumatic, sodium-retaining and uricosuric effects in man. J Pharmacol Exp Ther (1958) 1.07
The synthesis of L-ascorbic acid in the rat from D-glucuronolactone and L-gulonolactone. J Biol Chem (1956) 1.07
Metabolism of L-ascorbic acid-1-C14 in man. J Biol Chem (1958) 1.06
Studies on the glucuronic acid pathway of glucose metabolism. J Biol Chem (1959) 1.06
Missing step in man, monkey and guinea pig required for the biosynthesis of L-ascorbic acid. Nature (1957) 1.05
Zoxazolamine: physiological disposition, uricosuric properties. Am J Med (1958) 1.04
Effects of adrenocorticotropic hormone (ACTH) in gout. Am J Med (1950) 1.03
Observations on the drug-induced synthesis of D-glucuronic, L-gulonic and L-ascorbic acids in rats. J Pharmacol Exp Ther (1960) 1.03
Drug reactions characterized by cholestasis associated with intrahepatic biliary tract obstruction. Am J Med (1957) 1.02
STIMULATORY EFFECT OF PHENOBARBITAL ON THE METABOLISM OF DIPHENYLHYDANTOIN. J Pharmacol Exp Ther (1963) 1.02
Occurrence of methylated purine bases in yeast ribonucleic acid. J Biol Chem (1958) 1.01
The physiological disposition and fate of meperidine (demerol) in man and a method for its estimation in plasma. J Pharmacol Exp Ther (1955) 1.01